Gujarat Kidney & Super Speciality IPO GMP Today, Live Kostak and Subject to Sauda Price
Gujarat Kidney & Super Speciality IPO Grey Market Premium (GMP) today stands at ₹ 55, showing mild but stable interest in the grey market ahead of listing. The Kostak rate is currently not available, while the Subject to Sauda price is quoted at currently not available. On 4 January 2026, the IPO GMP recorded a high of ₹55 and a low of ₹55 on 4 January 2026, indicating steady grey market activity. You can check the day-wise GMP trend below to track price movement and investor sentiment over time.
Gujarat Kidney & Super Speciality IPO is scheduled to open for subscription on December 22, 2025. The public issue aims to raise around ₹250.80 crore and is offered in a price band of 108 to 114 per share, with a market lot of 128 shares. Investors are closely watching subscription data and grey market trends ahead of the listing.
Day-wise GMP Trend
| Date | GMP (₹) | Trend | GMP (%) | Kostak | Subject to Sauda |
|---|---|---|---|---|---|
| 04 Jan, 2026 | ₹ 55 | 10%% | - | - |
Gujarat Kidney & Super Speciality IPO Dates
| Event | Date |
|---|---|
| Open Date | 22 Dec, 2025 |
| Close Date | 24 Dec, 2025 |
| Allotment Date | 26 Dec, 2025 |
| Refund Date | 29 Dec, 2025 |
| Credit to Demat | 29 Dec, 2025 |
| Listing Date | 30 Dec, 2025 |
About Gujarat Kidney & Super Speciality IPO
Frequently Asked Questions about Gujarat Kidney & Super Speciality IPO
What is the GMP of Gujarat Kidney & Super Speciality IPO?
The current Grey Market Premium (GMP) of Gujarat Kidney & Super Speciality IPO is ₹ 55.
What is the Kostak Price of Gujarat Kidney & Super Speciality IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Gujarat Kidney & Super Speciality IPO is currently not available.
What is the Subject to Sauda Price of Gujarat Kidney & Super Speciality IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is currently not available.